Key statistics
On Friday, Insulet Corp (GOV:STU) closed at 208.30, 3.94% above its 52-week low of 200.40, set on Feb 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 210.70 |
|---|---|
| High | 212.50 |
| Low | 207.90 |
| Bid | 208.50 |
| Offer | 208.90 |
| Previous close | 213.00 |
| Average volume | 2.86 |
|---|---|
| Shares outstanding | 70.40m |
| Free float | 69.91m |
| P/E (TTM) | 70.45 |
| Market cap | 17.36bn USD |
| EPS (TTM) | 3.50 USD |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Press releases
- Insulet Reports Fourth Quarter and Full Year 2025 Results
- Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
- Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
- Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
- Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
- Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
More ▼
